Sarcoma
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor Prognostic Factors for Desmoid Tumors - Analyses From the DeFi Study"
FEATURING
Bruno Vincenzi
- 3 views
- July 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Highlights in Sarcomas
FEATURING
Robin Jones
- 99 views
- July 12, 2024
ecancer
ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"
FEATURING
Elizabeth Loggers
- 18 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sorafenib Treatment Duration in Desmoid Tumors"
FEATURING
Philippos Costa
- 43 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"
FEATURING
Viktor Grünwald
- 60 views
- June 12, 2024
- 1